Regulatory framework for access to safe, effective quality medicines
- PMID: 25310085
- DOI: 10.3851/IMP2902
Regulatory framework for access to safe, effective quality medicines
Abstract
Medicines of uncertain quality, safety and efficacy can be worse than no treatment at all. It is the responsibility of national medicines regulatory authorities to protect patients from harm. Yet, there are great disparities in regulatory capacity globally, preventing large populations from accessing the benefits of advances in the pharmaceutical field. This article describes the main regulatory functions and how they are applied to assure the quality, safety and efficacy of different types of medicines in different environments. It gives examples of initiatives that have increased access to good quality medicines worldwide and - more importantly - are laying the groundwork for collaborative approaches aiming to ensure that pharmaceutical products meet the same, stringent quality standards in all parts of the world.
Similar articles
-
Active pharmaceutical ingredients for antiretroviral treatment in low- and middle-income countries: a survey.Antivir Ther. 2014;19 Suppl 3(0 3):15-29. doi: 10.3851/IMP2897. Epub 2014 Oct 13. Antivir Ther. 2014. PMID: 25310430 Free PMC article.
-
The discovery and development of antiretroviral agents.Antivir Ther. 2014;19 Suppl 3:5-14. doi: 10.3851/IMP2896. Epub 2014 Oct 13. Antivir Ther. 2014. PMID: 25310317 Review.
-
Production of antiretroviral drugs in middle- and low-income countries.Antivir Ther. 2014;19 Suppl 3:49-55. doi: 10.3851/IMP2900. Epub 2014 Oct 13. Antivir Ther. 2014. PMID: 25310755 Review.
-
The AIDS response catalysing economic and social transformation: the importance of local pharmaceutical production.Antivir Ther. 2014;19 Suppl 3:3-4. doi: 10.3851/IMP2894. Epub 2014 Oct 13. Antivir Ther. 2014. PMID: 25310132 No abstract available.
-
Intellectual property rights, market competition and access to affordable antiretrovirals.Antivir Ther. 2014;19 Suppl 3:57-67. doi: 10.3851/IMP2901. Epub 2014 Oct 13. Antivir Ther. 2014. PMID: 25309984 Review.
Cited by
-
Generic substitution of antiretrovirals: patients' and health care providers' opinions.Int J STD AIDS. 2017 Oct;28(12):1239-1246. doi: 10.1177/0956462417696215. Epub 2017 Mar 2. Int J STD AIDS. 2017. PMID: 28632475 Free PMC article.
-
Harmonization of medical products regulation: a key factor for improving regulatory capacity in the East African Community.BMC Public Health. 2021 Jan 21;21(1):187. doi: 10.1186/s12889-021-10169-1. BMC Public Health. 2021. PMID: 33478421 Free PMC article.
-
Pharmacogenomics Implementation and Hurdles to Overcome; In the Context of a Developing Country.Iran J Pharm Res. 2021 Fall;20(4):92-106. doi: 10.22037/ijpr.2021.114899.15091. Iran J Pharm Res. 2021. PMID: 35194431 Free PMC article.
-
A 20-year evidence-based experience of the evolving medicine regulation in Zanzibar.J Pharm Policy Pract. 2024 Nov 7;17(1):2421273. doi: 10.1080/20523211.2024.2421273. eCollection 2024. J Pharm Policy Pract. 2024. PMID: 39524690 Free PMC article.
-
Bridging Gaps in Vaccine Access and Equity: A Middle Eastern Perspective.Vaccines (Basel). 2025 Jul 29;13(8):806. doi: 10.3390/vaccines13080806. Vaccines (Basel). 2025. PMID: 40872893 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical